CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

Despite advances in the pharmacologic and interventional treatment of coronary artery disease, atherosclerosis remains the leading cause of death worldwide. Atherosclerosis is a chronic inflammatory disease, and elevated expression of CCL19 and CCL21 has been observed in ruptured lesions of coronary...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Des Devel Ther
Prif Awduron: Akhavanpoor, Mohammadreza, Gleissner, Christian A, Gorbatsch, Stephanie, Doesch, Andreas O, Akhavanpoor, Hamidreza, Wangler, Susanne, Jahn, Frederik, Lasitschka, Felix, Katus, Hugo A, Erbel, Christian
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2014
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4251537/
https://ncbi.nlm.nih.gov/pubmed/25473269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S72394
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg